SweetBVGayWELeadyMAStumpfJL. Usefulness of herbal and dietary supplement references. Ann Pharmacother2003; 37: 494–9. DOI 10.1345/aph.1C046
2.
Package insert. Gleevec (imatinib mesylate). East Hanover, NJ: Novartis Pharmaceuticals Corporation, December 2002.
3.
MathijssenRHVerweijJde BruijnPLoosWJSparreboomA. Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst2002; 94: 1247–9.
4.
RichardsonMASandersTPalmerJLGreisingerASingletarySE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol2000; 18: 2505–14.
5.
TasakiKMaskarinecGShumayDMTatsumuraYKakaiH. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology2002; 11: 212–20.
6.
ErnstE. The risk–benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, saw palmetto, and kava. Ann Intern Med2002; 136: 42–53.